Quoin Pharmaceuticals (QNRX) Cash from Investing Activities (2021 - 2026)

Quoin Pharmaceuticals has reported Cash from Investing Activities for 6 years, with the latest figure at $4.1 million in Q1 2026.

• Quarterly Cash from Investing Activities rose 48.7% year-over-year to $4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.9 million (down 154.77% YoY) and the FY2025 annual result came in at -$4.3 million, down 126.54% from the prior year.
• Cash from Investing Activities grew to $4.1 million in Q1 2026 per QNRX's latest filing, from -$11.3 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $4.1 million in Q1 2026 and troughed at -$11.3 million in Q4 2025.
• A 5-year average of -$625496.8 and a median of $841761.0 in 2023 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities slumped 9108.48% in 2022, then jumped 316685.75% in 2024.
• Over 5 years, Cash from Investing Activities stood at -$9.9 million in 2022, then surged by 126.71% to $2.6 million in 2023, then sank by 220.21% to -$3.2 million in 2024, then tumbled by 254.54% to -$11.3 million in 2025, then soared by 136.55% to $4.1 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered $4.1 million, -$11.3 million, and $2.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.